Avenue Therapeutics Inc. – Filings and Transcripts

OTC: ATXI
Share price (10/7/26): $0.45
Market cap (10/7/26): $1.479 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Updated info for already-effective prospectus

Registration withdrawal request

Removal from listing

Shelf registration

Registration of securities for employees

Ownership Filter

Ikarian Capital, LLC

Fortress Biotech Inc.

Fortress Biotech Inc.

Fortress Biotech Inc.

Fortress Biotech Inc.

News Filter

Enters Into Exclusive Worldwide License Agreement for ATX-04 for the Treatment of Pompe Disease

Shareholder Vote Results

Shareholder Nominations, Other Events

Announces Acquisition of Subsidiary Baergic Bio by Axsome Therapeutics

Material Definitive Agreement, Termination of Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements or Exhibits

Proxies Filter

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Preliminary info

Other Filter

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness